secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moringa Acquisition Corp (—)
CIK:        0001835416
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001213900-24-071449
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.01, 3.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moringa Acquisition Corp completes de-SPAC merger with Silexion; begins trading as SLXN
--------------------------------------------------------------------------------

- Business combination closed Aug. 15, 2024; combined company renamed Silexion Therapeutics Corp, trading on Nasdaq under SLXN and SLXNW starting Aug. 16, 2024.
- Redemptions: 427,297 Moringa Class A shares redeemed; 87,722 public shares remained and converted into New Pubco ordinary shares.
- Post-combination: 9,768,396 ordinary shares and 5,940,000 warrants outstanding; Greenstar, L.P. purchased 200,000 shares at $10 each ($2M) in a private placement.
- Directors Ruth Alon, Michael Basch, Eric Brachfeld, Craig Marshak resigned; CEO Ilan Levin and CFO Gil Maman left; Ilan Hadar appointed as director.
- Moringa securities delisted from Nasdaq; public shareholders who did not redeem received shares of the combined company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/0001213900-24-071449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024071449/ea0212019-8k_moringa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer